In 2023, the mortality rate for bladder malignant neoplasms in Brazil among men was at a specific level and the forecast for 2024 shows a rate of 3.4 units per 100,000 males. Stabilization in 2024 and 2025 is expected, followed by a slight increase to 3.5 in 2026 and 3.6 in 2027 and 2028. The year-on-year growth from 2025 to 2026 is approximately 2.9%, while from 2026 to 2027 and 2027 to 2028, rates maintain a steady growth of around 2.9%. Overall, the compounded annual growth rate over the forecasted period is consistent and minor.

Future trends to watch for include:

Potential advances in medical research and treatment options which could impact mortality rates.
Changes in health policies or early diagnostic efforts in Brazil.
Demographic shifts which may influence the population at risk.